Anticoagulation in chronic kidney disease: from guidelines to clinical practice

V Aursulesei, II Costache - Clinical cardiology, 2019 - Wiley Online Library
Background Chronic kidney disease (CKD) is a major global public health problem, being
closely connected to cardiovascular disease. CKD involves an elevated thromboembolic risk …

Drug-induced liver injury: highlights of the recent literature

M Real, MS Barnhill, C Higley, J Rosenberg, JH Lewis - Drug safety, 2019 - Springer
Drug-induced liver injury (DILI), herbal-induced liver injury, and herbal and dietary
supplement (HDS)-induced liver injury are an important aspect of drug safety. Knowledge …

Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial …

CJM Klijn, M Paciaroni, E Berge… - European Stroke …, 2019 - journals.sagepub.com
Patients with ischemic stroke or transient ischemic attack and non-valvular atrial fibrillation
have a high risk of recurrent stroke and other vascular events. The aim of this guideline is to …

Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and extremes in body weight: insights from the ARISTOTLE trial

SH Hohnloser, M Fudim, JH Alexander, DM Wojdyla… - Circulation, 2019 - Am Heart Assoc
Background: Guidelines caution against the use of non–vitamin K antagonist oral
anticoagulants in patients with extremely high (> 120 kg) or low (≤ 60 kg) body weight …

Atrial fibrillation and cancer–an unexplored field in cardiovascular oncology

G Chu, HH Versteeg, AJ Verschoor, SA Trines… - Blood reviews, 2019 - Elsevier
An increasing body of evidence suggests an association between cancer and atrial
fibrillation (AF). The exact magnitude and underlying mechanism of this association are …

European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery …

G Boriani, L Fauchier, L Aguinaga, JM Beattie… - Ep …, 2019 - academic.oup.com
Terminology document, delivered in 2017, 1 critical care is the direct delivery by a physician
(s) or other qualified health care professional of medical care for a critically ill or critically …

Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French …

G Maura, C Billionnet, J Drouin, A Weill, A Neumann… - BMJ open, 2019 - bmjopen.bmj.com
Objectives To describe (i) the trend in oral anticoagulant (OAC) use following the
introduction of non-vitamin K antagonist oral anticoagulant (NOAC) therapy for stroke …

Acute stroke

A Morotti, L Poli, P Costa - Seminars in neurology, 2019 - thieme-connect.com
Stroke remains one of the leading determinants of death and severe disability worldwide. It
is a medical emergency with a narrow window for recognition and administration of outcome …

[HTML][HTML] Atrial fibrillation in the elderly

P Diez-Villanueva, F Alfonso - Journal of geriatric cardiology: JGC, 2019 - ncbi.nlm.nih.gov
Atrial fibrillation (AF) is the most common arrhythmia in elderly population, with age being
one of the most important factors involved in its pathogenesis. Conduction disturbances may …

Clinical benefit of direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic heart valves

V Russo, A Carbone, E Attena, A Rago, C Mazzone… - Clinical Therapeutics, 2019 - Elsevier
Purpose The use of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF)
and bioprosthetic heart valve is still controversial. The aim of this study was to compare the …